Tumor suppressor designated TS10Q23.3
View Patent ↗A specific region of chromosome 10 (10q23.3) has been implicated by series of studies to contain a tumor suppressor gene involved in gliomas, as well as a number of other human cancers. One gene within this region was identified, and the corresponding coding region of the gene represents a novel 47 kD protein. A domain of this product has an exact match to the conserved catalytic domain of protein tyrosine phosphatases, indicating a possible functional role in phosphorylation events. Sequence analyses demonstrated the a number of exons of the gene were deleted in tumor cell lines used to define the 10q23.3 region, leading to the classification of this gene as a tumor suppressor. Further analyses have demonstrated the presence of a number of mutations in the gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23.3, also are disclosed.
1. An isolated antibody or antibody fragment that binds specifically to a protein comprising the amino acid sequence encoded by the coding sequence comprising positions 1035 to 2243 of the nucleotide sequence of SEQ ID NO:1, wherein said antibody or antibody fragment does not specifically bind an epitope consisting of phosphotyrosine or phosphoserine.
2. The isolated antibody of claim 1 , wherein said antibody is a polyclonal antibody, a monoclonal antibody or a humanized antibody.
3. The isolated antibody of claim 2 wherein said antibody is a monoclonal antibody.
4. A kit comprising an isolated antibody or antibody fragment that binds specifically to a protein comprising the amino acid sequence encoded by the coding sequence comprising positions 1035 to 2243 of the nucleotide sequence of SEQ ID NO:1, wherein said antibody or antibody fragment does not specifically bind an epitope consisting of phosphotyrosine or phosphoserine.
5. An isolated antibody or antibody fragment that binds specifically to a protein comprising the amino acid sequence encoded by the coding sequence comprising positions 1035 to 2243 of the nucleotide sequence of SEQ ID NO:1, wherein said antibody or antibody fragment is non-cross reactive with other human proteins.